Structural and functional effects of adriamycin on cardiac cells in vitro

Theodore Lampidis, I. C. Henderson, M. Israel, G. P. Canellos

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The effects of Adriamycin (ADR) on the heart, seen clinically as transient electrocardiographic changes and cardiomyopathy, have been simulated in an in vitro cardiac cell system. Structural and functional alterations in cultured heart cells can be dissociated based upon ADR dose and length of exposure. At high ADR doses (100 to 200 μg/ml), cessation of beating was rapid, and structural changes consistent with the in vivo cardiomyopathic picture (vacuolization and nucleolar fragmentation) were observed. At low ADR doses (0.1 to 0.5 μg/ml), arrhythmias were produced in the absence of ultrastructural changes (within 48 hr); the incidence and severity of the arrhythmias were demonstrated to be dose dependent. Continued treatment of cultures at low dose levels for sustained periods of time (up to 17 days) resulted in a striking loss of muscle fiber without concomitant vacuolization and nucleolar fragmentation. An intermediate ADR dose of 10 μg/ml of 1 hr exposure caused vacuolization and cessation of beating, with lysis of cells within 72 hr. The parallel between the effects of ADR on in vitro cardiac cell structure and function with those seen in vivo suggests that this simple system may have value in studies directed towards the mechanism of ADR-induced cardiac toxicity and in the screening of anthracycline analogs for their potential effects on the heart.

Original languageEnglish
Pages (from-to)3901-3909
Number of pages9
JournalCancer Research
Volume40
Issue number11
StatePublished - Jan 1 1980
Externally publishedYes

Fingerprint

Doxorubicin
Cardiac Arrhythmias
Anthracyclines
In Vitro Techniques
Cardiomyopathies
Cultured Cells
Muscles
Incidence

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lampidis, T., Henderson, I. C., Israel, M., & Canellos, G. P. (1980). Structural and functional effects of adriamycin on cardiac cells in vitro. Cancer Research, 40(11), 3901-3909.

Structural and functional effects of adriamycin on cardiac cells in vitro. / Lampidis, Theodore; Henderson, I. C.; Israel, M.; Canellos, G. P.

In: Cancer Research, Vol. 40, No. 11, 01.01.1980, p. 3901-3909.

Research output: Contribution to journalArticle

Lampidis, T, Henderson, IC, Israel, M & Canellos, GP 1980, 'Structural and functional effects of adriamycin on cardiac cells in vitro', Cancer Research, vol. 40, no. 11, pp. 3901-3909.
Lampidis T, Henderson IC, Israel M, Canellos GP. Structural and functional effects of adriamycin on cardiac cells in vitro. Cancer Research. 1980 Jan 1;40(11):3901-3909.
Lampidis, Theodore ; Henderson, I. C. ; Israel, M. ; Canellos, G. P. / Structural and functional effects of adriamycin on cardiac cells in vitro. In: Cancer Research. 1980 ; Vol. 40, No. 11. pp. 3901-3909.
@article{918a5148d4644f098ccac86eaca74898,
title = "Structural and functional effects of adriamycin on cardiac cells in vitro",
abstract = "The effects of Adriamycin (ADR) on the heart, seen clinically as transient electrocardiographic changes and cardiomyopathy, have been simulated in an in vitro cardiac cell system. Structural and functional alterations in cultured heart cells can be dissociated based upon ADR dose and length of exposure. At high ADR doses (100 to 200 μg/ml), cessation of beating was rapid, and structural changes consistent with the in vivo cardiomyopathic picture (vacuolization and nucleolar fragmentation) were observed. At low ADR doses (0.1 to 0.5 μg/ml), arrhythmias were produced in the absence of ultrastructural changes (within 48 hr); the incidence and severity of the arrhythmias were demonstrated to be dose dependent. Continued treatment of cultures at low dose levels for sustained periods of time (up to 17 days) resulted in a striking loss of muscle fiber without concomitant vacuolization and nucleolar fragmentation. An intermediate ADR dose of 10 μg/ml of 1 hr exposure caused vacuolization and cessation of beating, with lysis of cells within 72 hr. The parallel between the effects of ADR on in vitro cardiac cell structure and function with those seen in vivo suggests that this simple system may have value in studies directed towards the mechanism of ADR-induced cardiac toxicity and in the screening of anthracycline analogs for their potential effects on the heart.",
author = "Theodore Lampidis and Henderson, {I. C.} and M. Israel and Canellos, {G. P.}",
year = "1980",
month = "1",
day = "1",
language = "English",
volume = "40",
pages = "3901--3909",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Structural and functional effects of adriamycin on cardiac cells in vitro

AU - Lampidis, Theodore

AU - Henderson, I. C.

AU - Israel, M.

AU - Canellos, G. P.

PY - 1980/1/1

Y1 - 1980/1/1

N2 - The effects of Adriamycin (ADR) on the heart, seen clinically as transient electrocardiographic changes and cardiomyopathy, have been simulated in an in vitro cardiac cell system. Structural and functional alterations in cultured heart cells can be dissociated based upon ADR dose and length of exposure. At high ADR doses (100 to 200 μg/ml), cessation of beating was rapid, and structural changes consistent with the in vivo cardiomyopathic picture (vacuolization and nucleolar fragmentation) were observed. At low ADR doses (0.1 to 0.5 μg/ml), arrhythmias were produced in the absence of ultrastructural changes (within 48 hr); the incidence and severity of the arrhythmias were demonstrated to be dose dependent. Continued treatment of cultures at low dose levels for sustained periods of time (up to 17 days) resulted in a striking loss of muscle fiber without concomitant vacuolization and nucleolar fragmentation. An intermediate ADR dose of 10 μg/ml of 1 hr exposure caused vacuolization and cessation of beating, with lysis of cells within 72 hr. The parallel between the effects of ADR on in vitro cardiac cell structure and function with those seen in vivo suggests that this simple system may have value in studies directed towards the mechanism of ADR-induced cardiac toxicity and in the screening of anthracycline analogs for their potential effects on the heart.

AB - The effects of Adriamycin (ADR) on the heart, seen clinically as transient electrocardiographic changes and cardiomyopathy, have been simulated in an in vitro cardiac cell system. Structural and functional alterations in cultured heart cells can be dissociated based upon ADR dose and length of exposure. At high ADR doses (100 to 200 μg/ml), cessation of beating was rapid, and structural changes consistent with the in vivo cardiomyopathic picture (vacuolization and nucleolar fragmentation) were observed. At low ADR doses (0.1 to 0.5 μg/ml), arrhythmias were produced in the absence of ultrastructural changes (within 48 hr); the incidence and severity of the arrhythmias were demonstrated to be dose dependent. Continued treatment of cultures at low dose levels for sustained periods of time (up to 17 days) resulted in a striking loss of muscle fiber without concomitant vacuolization and nucleolar fragmentation. An intermediate ADR dose of 10 μg/ml of 1 hr exposure caused vacuolization and cessation of beating, with lysis of cells within 72 hr. The parallel between the effects of ADR on in vitro cardiac cell structure and function with those seen in vivo suggests that this simple system may have value in studies directed towards the mechanism of ADR-induced cardiac toxicity and in the screening of anthracycline analogs for their potential effects on the heart.

UR - http://www.scopus.com/inward/record.url?scp=0018933538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018933538&partnerID=8YFLogxK

M3 - Article

VL - 40

SP - 3901

EP - 3909

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 11

ER -